Notice of Results

Hutchison China Meditech Limited
18 July 2007



                  Hutchison China MediTech Limited ('Chi-Med')
                                   (AIM: HCM)

                           Notice of Interim Results


London, Wednesday, 18 July 2007: Chi-Med will be announcing its interim results
for the six months ended 30 June 2007 on Thursday, 9 August 2007.

                                      Ends


Enquiries

Chi-Med                                         Telephone: [phone]
Christian Hogg, CEO

Citigate Dewe Rogerson                          Telephone: [phone]
Anthony Carlisle                                Mobile: [phone]
Yvonne Alexander                                Mobile: [phone]


About Chi-Med

Chi-Med is the holding company of a pharmaceutical and healthcare group based
primarily in China and was admitted to trading on the Alternative Investment
Market of the London Stock Exchange in May 2006.  Chi-Med is focused on
researching, developing, manufacturing, and selling pharmaceuticals, health
supplements and other consumer health and personal care products derived from
Traditional Chinese Medicine and botanical ingredients.

Chi-Med is majority owned by Hutchison Whampoa Limited, an international
corporation listed on the Main Board of The Stock Exchange of Hong Kong Limited.


                      This information is provided by RNS
            The company news service from the London Stock Exchange